Keywords: strong, results, anadys, drug-resistant, hep, drug, pharmaceuticals

Strong results for Anadys' drug-resistant hep B drug

Article | 25 April 2005

Print This

Anadys Pharmaceuticals, a US drugmaker focused on anti-infectives, has reported positive data from an ongoing Phase II trial of ANA380 ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in